Zing Open Zing
Health

Pope Leo requires no further lung cancer treatment after successful surgery

22 October 2026 · Source balance: Centre

Pope Leo XIV, the 71-year-old American pontiff, has been cleared by doctors to require no additional cancer treatment following his October 13 lung surgery. Doctors removed the lower lobe of his right lung after discovering a nodule during routine medical tests. Tissue analysis confirmed the cancer was localized lung adenocarcinoma, the most common type of lung cancer. The 90-minute minimally invasive procedure was successful with no complications. Pope Leo was discharged after four days, significantly earlier than the anticipated week-long stay. He has resumed his public duties, leading his general audience at St. Peter's Square on October 21. Medical experts note his prognosis is excellent due to early detection. The pope's decision to publicly announce the surgery before the procedure was unusually transparent for the Vatican and breaks with tradition of secrecy surrounding papal health matters.

Key facts

  • Pope Leo XIV, age 71, underwent lung surgery on October 13, 2026
  • Doctors removed the lower lobe of his right lung
  • Final pathology confirmed localized lung adenocarcinoma, the most common type of lung cancer
  • The 90-minute minimally invasive procedure had no complications
  • Pope Leo was discharged after 4 days instead of the anticipated 7-day hospital stay
  • He returned to public duties on October 21, just 8 days after surgery
  • No additional treatment such as chemotherapy or radiation is necessary
  • Lung adenocarcinoma accounts for roughly 40 percent of all lung cancer cases
  • The nodule was discovered incidentally during routine medical examinations
  • Pope Leo is the first American pope, elected in May 2025

Limits of this briefing

Most coverage reflects mainstream medical and news outlets; limited perspective from explicitly conservative or left-leaning religious organizations focused on this specific medical story. Long-term follow-up imaging will be needed to monitor for recurrence.

Sources

More stories

See all latest stories